Skip to main content
Equibles

Bruce Given

Analyst

Interim Chief Medical Scientist

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Bruce Given

Bruce Given is recorded as Analyst at Interim Chief Medical Scientist. Bruce Given was last confirmed as COO at Arrowhead Pharmaceuticals, Inc. (ARWR) in a filing dated January 28, 2020. The proxy statement of Arrowhead Pharmaceuticals, Inc. reports total compensation of $16,343,808 for Bruce Given in fiscal 2020, including a base salary of $409,615. Disclosed compensation is on record for 3 fiscal years. Bruce Given has spoken on 5 earnings calls across 1 company, most recently for Arrowhead Pharmaceuticals, Inc. on February 10, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Interim Chief Medical Scientist

    Analyst

    Source not stated

    Current

  • Start not stated–2020-01-28

    Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Arrowhead Pharmaceuticals, Inc. (ARWR) $409,615 $16,343,808
2019 Arrowhead Pharmaceuticals, Inc. (ARWR) $488,750 $3,958,759
2018 Arrowhead Pharmaceuticals, Inc. (ARWR) $450,362 $1,552,061

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.